Clik here to view.
Clik here to view.
昆泰在韩国获得最佳职场称号
韩国首尔 (美国商业资讯)–昆泰(Quintiles)今天宣布，该公司在由最佳职场研究所(Great Place to Work® Institute)主持的评选中被选为韩国最佳职场之一；这是昆泰韩国(Quintiles Korea)首次获此殊荣，并进入最佳职场研究所授予类似奖励的全球其他昆泰办事处的行列。 昆泰韩国是最高级别“大奖”(Grand...
View ArticleClik here to view.
クインタイルズ、韓国で「最も働きがいのある会社」に選ばれる
韓国ソウル 韓国ソウル （ビジネスワイヤ） — クインタイルズは本日、グレート・プレース・トゥ・ワーク・インスティテュートから「韓国の最も働きがいのある会社」の1つに選ばれたと発表しました。クインタイルズ韓国がこの賞を獲得したのは今回が初めてで、グレート・プレース・トゥ・ワーク・インスティテュートから同様の賞を獲得している世界各地のその他多くのクインタイルズのオフィスに加わります。...
View ArticleClik here to view.
ResolutionMD® Receives Certification for Web and Mobile Diagnosis in Australia
CALGARY Calgary Scientific Inc., a company known for creating transformative technology for the medical industry and beyond, announced today that ResolutionMD® has received certification from the...
View ArticleClik here to view.
Wipro Healthcare and Life Sciences Emerges Star Performer in Everest Group...
BANGALORE, India & EAST BRUNSWICK, N.J. Wipro Ltd. (NYSE:WIT), a leading global information technology, consulting and business process services company, today announced that it has been named a...
View ArticleClik here to view.
株式会社東芝が日本で新たに開始するゲノム解析サービスのためにアフィメトリクス社のAxiomプラットフォームを採用
カリフォルニア州サンタクララ発 （ビジネスワイヤ） — アフィメトリクス社（NASDAQ：AFFX）は、株式会社東芝（TYO：6502）ヘルスケア社が新たに開始するゲノム解析サービスのプラットフォームとして、Axiom®ジェノタイピングソリューションが採用されたことを発表します。当社は、株式会社東芝と協働し、Axiomプラットフォーム技術を用いて｢ジャポニカアレイ®...
View ArticleClik here to view.
Toshiba Corporation Selects Affymetrix Axiom Platform for Its Newly Launched...
SANTA CLARA, Calif. Affymetrix (NASDAQ: AFFX) announces its Axiom® Genotyping Solution platform has been selected by Toshiba Corporation’s (TYO: 6502) Healthcare Company as the platform for its...
View ArticleClik here to view.
HanAll Biopharma Co., Ltd. and Open Monoclonal Technology Announce Collaboration
SEOUL, South Korea & PALO ALTO, Calif. HanAll BioPharma Co., Ltd. (HanAll), a public Korean biopharmaceutical company and leader in development of novel biologics and new chemical entities in...
View ArticleClik here to view.
Otsuka Pharmaceutical to Acquire Avanir Pharmaceuticals
TOKYO Otsuka Pharmaceutical Co., Ltd. is pleased to announce an agreement with Avanir Pharmaceuticals, Inc. (“Avanir”) in which Otsuka America, Inc., a US subsidiary, acquires Avanir for USD 3.5...
View ArticleClik here to view.
Edeniq and Global Bio-chem Enter Into Joint Development Agreement
VISALIA, Calif. Edeniq, Inc. (“Edeniq”), a biorefining and cellulosic technology company, today announced a Joint Development Agreement with Global Bio-chem Technology Group Limited (“Global...
View ArticleClik here to view.
CANbridge Life Sciences Raises $10 Million in Series A Round Led by Qiming...
BEIJING CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, announced that it has raised $10 million in a Series A round from...
View ArticleClik here to view.
Biogen Idec to Present Data from Hematology Programs, Including ELOCTATE™ and...
CAMBRIDGE, Mass. Biogen Idec (NASDAQ: BIIB) will present data supporting its approved hemophilia therapies at the 56th Annual Meeting of the American Society of Hematology (ASH) taking place in San...
View ArticleClik here to view.
8th Annual OneMedForum San Francisco Expands Its China Forum into Partnering...
NEW YORK OneMedForum announced today that its 8th annual OneMedForum conference, to be held at the San Francisco Marriott Marquis, Jan. 12-13, 2015, will expand its annual China Forum event at the...
View ArticleClik here to view.
Cytori Expects New Japan Laws to Boost Adoption of Cytori Cell Therapy
SAN DIEGO Cytori Therapeutics, Inc. (NASDAQ: CYTX) today confirmed that two Japanese regenerative medicine laws, which went into effect on November 25, 2014, remove regulatory uncertainties and...
View ArticleClik here to view.
テラヴェクティスが自社レンチウイルスベクター技術の知的財産権をさらに強化
パリ （ビジネスワイヤ） — 完全統合型の創薬・臨床開発バイオテクノロジーを手掛ける企業として治療用ワクチンと免疫療法の開発に傾注するテラヴェクティスは、最初の申請（ウェブサイト）からわずか2年後に欧州特許「Lentiviral Vectors Containing an MHC Class I...
View ArticleClik here to view.
昆泰连续3年荣获SCRIP最佳合同研究组织奖
北卡罗莱纳州研究三角园区 (美国商业资讯) – 昆泰今天宣布，该公司连续3年获得每年一次的SCRIP “最佳合同研究组织”奖。这是5年来该公司第四次获得此类奖。SCRIP奖表彰生物制药业的翘楚，由生命科学领域的12位专家组成的独立评委进行评审。 IBI Pharma News & Datamonitor Healthcare全球内容总监Mike...
View ArticleClik here to view.
Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from...
SAN FRANCISCO Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today reported data demonstrating that Hodgkin lymphoma (HL) patients at risk of relapse...
View ArticleClik here to view.
U.S. FDA Approves the Labeling Update of Abilify Maintena® (Aripiprazole) for...
TOKYO & VALBY, Denmark Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) announced that the U.S. Food and Drug Administration (FDA) approved the labeling update of Abilify...
View ArticleClik here to view.
「ABILIFY MAINTENA®」（エビリファイ メンテナ）米国で統合失調症の急性期試験データを添付文書に追加
東京とコペンハーゲン （ビジネスワイヤ） –大塚製薬株式会社（本社：東京都、代表取締役社長：岩本太郎、以下「大塚製薬」）とH.ルンドベックA/S（本社：デンマーク、コペンハーゲン、取締役会議長：ホーカン ビョークルン、以下「ルンドベック社」）は、急性期統合失調症患者さんを対象とした臨床試験の結果により、持続性懸濁注射剤である「Abilify Maintena®」（エビリファイ...
View ArticleClik here to view.
Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS®...
SAN FRANCISCO Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced four-year overall survival (OS) data from the ADCETRIS (brentuximab vedotin)...
View Article